Viome raises $54M to develop saliva-based cancer diagnostics and expand microbiome consumer business

Viome Life Sciences raised $54 million to advance cancer diagnostics and support its consumer microbiome testing and customized supplement business, bringing total funding to over $125 million while targeting $100M revenue and one million customers next year.

NNaveen Jain VViome UUniversity of Washington